OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.

OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.

We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor. 


Archiving: full-text archived in CLOCKSS.

Publication Speed (median values for papers published in 2022): Submission to First Decision: 6 weeks; Submission to Acceptance: 14 weeks; Acceptance to Publication: 6 days (1-2 days of FREE language polishing included)

Current Issue: 2023  Archive: 2022 2021 2020 2019 2018 2017

Special Issue

New Challenges in Machine Perfusion in Organ Transplantation

Submission Deadline: December 15, 2023 (Open) Submit Now

Guest Editor

Davide Ghinolfi, MD (Biography)

Division of Hepatic Surgery and Liver Transplantation, University of Pisa Medical School Hospital, Pisa, Italy

Website | E-Mail

Research Interests: Proper selection of extended criteria grafts, DCD, the identification of markers of organ viability during normothermic regional and machine perfusion and organ therapeutics

About This Topic

In the last years, the field of organ transplantation has been revolutionized by the emergence and rapid adoption of machine perfusion technologies, such as normothermic regional perfusion, normothermic machine perfusion and hypothermic oxygenated machine perfusion. The use of the so-called “extended criteria” donors is largely adopted to improve the availability of donor allografts but these organs are more vulnerable to ischemia-reperfusion injury in comparison to standard grafts, hence carrying an increased risk of post-transplant dysfunction. Machines perfusion were introduced in clinical practice to minimize the duration of static cold storage, protect organs from the detrimental effects of ischemia-reperfusion injury, facilitate repair/regeneration of extended criteria donor grafts, expand donor pool, and improve graft survival after transplant. Nevertheless, machine perfusion have the potential to become the new standard for organ procurement and preservation only if the risen costs, logistic complexity and extra time and personnel requirements are objectively justified by increased available grafts or decreased post-transplant complications. The transition of these technologies into clinical practice does not mark the end of a development process but, rather, the start of the clinical evolution of these devices and their applications. Fulfilling the true potential of these technologies can only be realized by appreciating their existing limitations and identifying new boundaries to push (1).

(1) Ghinolfi, D. 2022. MACHINE PERFUSION IN ORGAN TRANSPLANTATION. European Journal of Transplantation. 1, (Oct. 2022), 2–3. DOI:https://doi.org/10.57603/EJT-002.


Machine perfusion technologies;
Normothermic regional perfusion;
Normothermic machine perfusion;
Hypothermic oxygenated machine perfusion;
Extended criteria donor grafts;
Ischemia-reperfusion injury;
Graft survival;
Liver transplantation